Position in CDXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,721,489
+$217,514 QoQ
Shares Held
4,123,613
+3.3% QoQ
Ownership
4.54%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Derivatives in CDXS
reported options exposure · as of Sep 30, 2022CallValue
$303,000
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Nantahala Capital Management, LLC holds $503,631,710 across 52 Biotechnology names. CDXS ranks #28 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SVRA |
Savara Inc
|
7,344,783 | $40,102,515 | |
| 2 | TNGX |
Tango Therapeutics, Inc.
|
1,250,452 | $26,159,455 | |
| 3 | LBRX |
Lb Pharmaceuticals Inc
|
1,052,894 | $25,964,366 | |
| 4 | MLYS |
Mineralys Therapeutics, Inc.
|
895,481 | $24,258,580 | |
| 5 | ZVRA |
Zevra Therapeutics, Inc.
|
2,521,936 | $23,504,443 | |
| 6 | FULC |
Fulcrum Therapeutics, Inc.
|
3,050,040 | $23,393,806 | |
| 7 | ABEO |
Abeona Therapeutics Inc.
|
5,013,052 | $22,458,472 | |
| 8 | VSTM |
Verastem, Inc.
|
3,584,820 | $18,999,546 |
All Filings in CDXS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,721,489 | 4,123,613 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,503,975 | 3,990,169 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,834,710 | 4,030,619 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,834,710 | 4,030,619 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,614,365 | 2,830,619 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,554,718 | 2,841,660 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,140,848 | 2,967,808 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,251,828 | 3,629,622 | Shares | Sole | 2024-08-20 | |
| 2024-03-31 | $15,571,954 | 4,461,878 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,008,354 | 4,592,903 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $9,581,247 | 5,069,443 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $14,099,856 | 5,035,663 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $21,327,454 | 5,151,559 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $20,913,064 | 4,487,782 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $303,000 | 50,000 | Call | Sole | 2022-11-10 | |
| 2022-09-30 | $27,294,294 | 4,504,009 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $43,096,225 | 4,120,098 | Shares | Sole | 2022-08-15 | |
| 2022-06-30 | $523,000 | 50,000 | Call | Sole | 2022-08-15 | |
| 2022-03-31 | $69,758,470 | 3,383,049 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $100,504,813 | 3,214,097 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $87,207,345 | 3,749,241 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $87,495,517 | 3,861,232 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,229,193 | 53,700 | Call | Sole | 2021-05-14 | |
| 2021-03-31 | $95,951,080 | 4,191,834 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $109,163,534 | 5,000,620 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $6,549,000 | 300,000 | Call | Sole | 2021-02-16 | |
| 2020-09-30 | $62,967,302 | 5,363,484 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $61,143,717 | 5,363,484 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $59,856,481 | 5,363,484 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||